Centro Médico Teknon
| Turkey | Austria | Spain | |
| Stem cell therapy for Alzheimer's disease | from $15,000 | from $40,000 | from $20,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Alzheimer's disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Alzheimer's disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Alzheimer's disease treatment journey.
Dr. Anna Pujol has 36 years of neurology experience and specializes in Alzheimer's disease at Centro Médico Teknon.
Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.
Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.
Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.
Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.